EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case–Control Study

Mengzhen Zhang, Wenli Zhang, Chunlei Zhou, Jiaming Chang, Jiabin Liu, Lei Lin, Xinxin Zhang, Liping Chen, Jing He iD, Baowei Han

Journal of Cellular and Molecular Medicine · 2025-09 · 29 (18)

DOI: 10.1111/jcmm.70848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.09.2025. Verfasst von Mengzhen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Diseas…. Hauptthemen laut MEDLINE: Neuroblastoma, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, tRNA Methyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science and Technology Project, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma is the most common extracranial solid tumour in children, and genetic susceptibility plays a crucial role in its development. The impact of tRNA Dimethyltransferase 1 (TRDMT1), a primary methyltransferase catalysing 5‐methylcytosine (m5C) RNA modification, on neuroblastoma susceptibility remains unexplored. We conducted a case–control study involving 402 neuroblastoma patients and 473 controls from Jiangsu, China. TRDMT1 polymorphisms (rs7074891 T>C, rs10904887 T>C and rs2273734 C>T) were genotyped via the TaqMan assay. Logistic regression was used to assess odds ratios (ORs) and 95% confidence intervals (CIs), while stratification analysis and expression quantitative trait locus (eQTL) analysis were used to examine subgroup‐specific effects and regulatory impacts. Additionally, clinical correlation analysis and survival analysis were performed on neuroblastoma datasets used to evaluate. The rs7074891 TC/CC genotype reduced neuroblastoma risk (adjusted OR = 0.75, 95% CI = 0.57–0.98, p = 0.036), especially in children aged ≤ 18 months and those with mediastinal‐origin tumours. Conversely, the rs10904887 CC (adjusted OR = 1.73, 95% CI = 1.27–2.38, p = 0.0006) and rs2273734 TT genotypes (adjusted OR = 1.80, 95% CI = 1.09–2.97, p = 0.023) were associated with increased risk, with distinct subgroup‐specific effects. Combined 1–3 risk genotypes further confirmed increased susceptibility (adjusted OR = 1.81, 95% CI = 1.38–2.37, p < 0.0001), particularly in males and older children. eQTL analysis revealed that the rs7074891 C and rs10904887 C alleles increased TRDMT1 expression, whereas the rs2273734 T allele decreased it. Elevated TRDMT1 expression was correlated with poor prognosis and high‐risk clinical features. TRDMT1 polymorphisms are significantly associated with neuroblastoma susceptibility, providing insights into their genetic and epigenetic mechanisms and potential as biomarkers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaGenetic Predisposition to DiseasePolymorphism, Single NucleotidetRNA MethyltransferasesGenetic Association StudiesHumansCase-Control StudiesMaleFemaleInfantChild, PreschoolQuantitative Trait LociChildGenotype

Stichwörter der Autor:innen

TRDMT1m5C modificationneuroblastomapolymorphismsusceptibility

Substanzen

tRNA Methyltransferases

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical Un…
  • Department of Pathology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of General Surgery, Luoyang Maternal and Child Health Hospital, Luoyang, Henan, China.

ORCID-Profile: Jing He

Förderung

  • Guangzhou Science and Technology Project
  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhang, M., Zhang, W., Zhou, C., Chang, J., Liu, J., Lin, L., Zhang, X., Chen, L., He, J., & Han, B. (2025). Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case–Control Study. Journal of Cellular and Molecular Medicine, 29(18). https://doi.org/10.1111/jcmm.70848

Vancouver

Zhang M, Zhang W, Zhou C, Chang J, Liu J, Lin L, et al. Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case–Control Study. Journal of Cellular and Molecular Medicine. 2025;29(18). doi:10.1111/jcmm.70848

BibTeX
@article{Zhang2025,
  author = {Zhang, Mengzhen and Zhang, Wenli and Zhou, Chunlei and Chang, Jiaming and Liu, Jiabin and Lin, Lei and Zhang, Xinxin and Chen, Liping and He, Jing and Han, Baowei},
  title = {Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case–Control Study},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {18},
  doi = {10.1111/jcmm.70848}
}
Kostenlos starten →